BDSX

Biodesix, Inc. Common Stock

29.77

USD

+0.48

+1.65%

Sep 24, 10:25 UTC -4

Open

Biodesix, Inc. Common Stock Profile

About

Biodesix Inc. is a data-driven diagnostic solutions company. It offers blood-based tests across the lung cancer continuum of care. The company also offers include diagnostic research, clinical research, development, and testing services to biopharmaceutical companies, as well as develops and commercializes companion diagnostics. Biodesix Inc. is based in Boulder, Colorado.

Info & Links

CEO

Scott Hutton

Headquarters

919 WEST DILLON RD.
LOUISVILLE, CO 80027, UNITED STATES

Auditor

KPMG LLP

Share holders

228

Employees

334

Biodesix, Inc. Common Stock Statistics

Valuation Measures

Market Capitalization²

314.15M

Enterprise Value

330.97M

Enterprise Value/EBITDA(ttm)

-24.25

Price to Earnings Ratio(ttm)

Price to Sales(ttm)

2.89

Price to Book(mrq)

32.48

Price to Cash(ytd)

Profitability

Gross Margin(ttm)

82.44%

Operating Margin(ttm)

-26.97%

Profit Margin(ttm)

-27.86%

Return on Equity(ttm)

-788.19%

Return on Invested Capital(ttm)

-55.06%

Return on Assets(ttm)

-30.33%

Income Statement

Revenue(ttm)

102.94M

Revenue Per Share(ttm)

9.76

Gross Profit(ttm)

84.93M

EBITDA(ttm)³

-13.65M

Net Income Available to Common(ttm)

-27.76M

Diluted EPS(ttm)

-3.17

Share Statistics

Beta (5Y Monthly)

0.60

52-Week Change

268.49%

S&P 500 52-Week Change

19.49%

S&P 500 Member

Stock Optionable

Yes

Total Shares Outstanding¹

10.55M

Dividend Yield

0.00%

Float⁴

8.10M

% Held by Insiders

23.20%

% Held by Institutions

20.96%

Balance Sheet

Total Cash(mrq)

30.00M

Total Cash Per Share(mrq)

2.84

Total Debt(mrq)

46.82M

Total Debt/Equity(mrq)

512.00%

Current Ratio(mrq)

2.85%

Quick Ratio(mrq)

2.85%

Book Value Per Share(mrq)

0.87

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.14

Free Cash Flow(ytd)

-12.01M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
2 Market Cap is calculated using total shares outstanding and the most recent share price.
3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.